BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 121016
Published online Aug 27, 2026. doi: 10.4240/wjgs.121016
Figure 2
Figure 2 Nomogram for the prediction and receiver operating characteristic curve of prediction of 1-, 2- and 3-year overall survival. A-C: Nomogram for the prediction of 1-, 2- and 3-year overall survival (OS) after transjugular intrahepatic portosystemic shunt procedure (A), training set (B) and validation set (C); D and E: Receiver operating characteristic curve predicting one-, two- and three-year OS in the training set (D) and validation set (E). HCC: Hepatocellular carcinoma; MELD: Model for End-Stage Liver Disease; OS: Overall survival; AUC: Area under the receiver operating characteristic curve.


Write to the Help Desk